In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, looks back to 2024 and discusses some of the industry’s ...
End-to-end offering is designed to streamline site activation and optimize visibility in critical research processes.
Use of decentralized approach in a Phase 1 pharmacokinetic trial shows the ability to enable remote data collection and ...